Report Detail

Request for Sample of this report

Pharma & Healthcare Global Cannabis Use Disorder Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4746871
    • |
  • 05 October, 2026
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Cannabis Use Disorder Treatment market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Cannabis Use Disorder Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cannabis Use Disorder Treatment market size and forecasts, in consumption value ($ Million), 2021-2032
Global Cannabis Use Disorder Treatment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Cannabis Use Disorder Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Cannabis Use Disorder Treatment market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cannabis Use Disorder Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cannabis Use Disorder Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior, Mallinckrodt, Noramco, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cannabis Use Disorder Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tobacco/Nicotine and Vaping
Alcohol
Marijuana
Synthetic Cannabinoids
Others
Market segment by Application
Hospitals and Clinics
Rehabilitation Centers
Others
Market segment by players, this report covers
AbbVie
Alkermes
BioCorRx
Cipla Limited
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals Limited
Intas Pharmaceuticals Limited
Indivior
Mallinckrodt
Noramco
Orexo AB
Purdue Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cannabis Use Disorder Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cannabis Use Disorder Treatment, with revenue, gross margin, and global market share of Cannabis Use Disorder Treatment from 2021 to 2026.
Chapter 3, the Cannabis Use Disorder Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cannabis Use Disorder Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cannabis Use Disorder Treatment.
Chapter 13, to describe Cannabis Use Disorder Treatment research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cannabis Use Disorder Treatment by Type
    • 1.3.1 Overview: Global Cannabis Use Disorder Treatment Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Cannabis Use Disorder Treatment Consumption Value Market Share by Type in 2025
    • 1.3.3 Tobacco/Nicotine and Vaping
    • 1.3.4 Alcohol
    • 1.3.5 Marijuana
    • 1.3.6 Synthetic Cannabinoids
    • 1.3.7 Others
  • 1.4 Global Cannabis Use Disorder Treatment Market by Application
    • 1.4.1 Overview: Global Cannabis Use Disorder Treatment Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals and Clinics
    • 1.4.3 Rehabilitation Centers
    • 1.4.4 Others
  • 1.5 Global Cannabis Use Disorder Treatment Market Size & Forecast
  • 1.6 Global Cannabis Use Disorder Treatment Market Size and Forecast by Region
    • 1.6.1 Global Cannabis Use Disorder Treatment Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Cannabis Use Disorder Treatment Market Size by Region, (2021-2032)
    • 1.6.3 North America Cannabis Use Disorder Treatment Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Cannabis Use Disorder Treatment Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Cannabis Use Disorder Treatment Market Size and Prospect (2021-2032)
    • 1.6.6 South America Cannabis Use Disorder Treatment Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Cannabis Use Disorder Treatment Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie Cannabis Use Disorder Treatment Product and Solutions
    • 2.1.4 AbbVie Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 Alkermes
    • 2.2.1 Alkermes Details
    • 2.2.2 Alkermes Major Business
    • 2.2.3 Alkermes Cannabis Use Disorder Treatment Product and Solutions
    • 2.2.4 Alkermes Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Alkermes Recent Developments and Future Plans
  • 2.3 BioCorRx
    • 2.3.1 BioCorRx Details
    • 2.3.2 BioCorRx Major Business
    • 2.3.3 BioCorRx Cannabis Use Disorder Treatment Product and Solutions
    • 2.3.4 BioCorRx Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BioCorRx Recent Developments and Future Plans
  • 2.4 Cipla Limited
    • 2.4.1 Cipla Limited Details
    • 2.4.2 Cipla Limited Major Business
    • 2.4.3 Cipla Limited Cannabis Use Disorder Treatment Product and Solutions
    • 2.4.4 Cipla Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Cipla Limited Recent Developments and Future Plans
  • 2.5 Dr. Reddy’s Laboratories
    • 2.5.1 Dr. Reddy’s Laboratories Details
    • 2.5.2 Dr. Reddy’s Laboratories Major Business
    • 2.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product and Solutions
    • 2.5.4 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Dr. Reddy’s Laboratories Recent Developments and Future Plans
  • 2.6 Glenmark Pharmaceuticals Limited
    • 2.6.1 Glenmark Pharmaceuticals Limited Details
    • 2.6.2 Glenmark Pharmaceuticals Limited Major Business
    • 2.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
    • 2.6.4 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Glenmark Pharmaceuticals Limited Recent Developments and Future Plans
  • 2.7 Intas Pharmaceuticals Limited
    • 2.7.1 Intas Pharmaceuticals Limited Details
    • 2.7.2 Intas Pharmaceuticals Limited Major Business
    • 2.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product and Solutions
    • 2.7.4 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Intas Pharmaceuticals Limited Recent Developments and Future Plans
  • 2.8 Indivior
    • 2.8.1 Indivior Details
    • 2.8.2 Indivior Major Business
    • 2.8.3 Indivior Cannabis Use Disorder Treatment Product and Solutions
    • 2.8.4 Indivior Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Indivior Recent Developments and Future Plans
  • 2.9 Mallinckrodt
    • 2.9.1 Mallinckrodt Details
    • 2.9.2 Mallinckrodt Major Business
    • 2.9.3 Mallinckrodt Cannabis Use Disorder Treatment Product and Solutions
    • 2.9.4 Mallinckrodt Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Mallinckrodt Recent Developments and Future Plans
  • 2.10 Noramco
    • 2.10.1 Noramco Details
    • 2.10.2 Noramco Major Business
    • 2.10.3 Noramco Cannabis Use Disorder Treatment Product and Solutions
    • 2.10.4 Noramco Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Noramco Recent Developments and Future Plans
  • 2.11 Orexo AB
    • 2.11.1 Orexo AB Details
    • 2.11.2 Orexo AB Major Business
    • 2.11.3 Orexo AB Cannabis Use Disorder Treatment Product and Solutions
    • 2.11.4 Orexo AB Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Orexo AB Recent Developments and Future Plans
  • 2.12 Purdue Pharma
    • 2.12.1 Purdue Pharma Details
    • 2.12.2 Purdue Pharma Major Business
    • 2.12.3 Purdue Pharma Cannabis Use Disorder Treatment Product and Solutions
    • 2.12.4 Purdue Pharma Cannabis Use Disorder Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Purdue Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cannabis Use Disorder Treatment Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Cannabis Use Disorder Treatment by Company Revenue
    • 3.2.2 Top 3 Cannabis Use Disorder Treatment Players Market Share in 2025
    • 3.2.3 Top 6 Cannabis Use Disorder Treatment Players Market Share in 2025
  • 3.3 Cannabis Use Disorder Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Cannabis Use Disorder Treatment Market: Region Footprint
    • 3.3.2 Cannabis Use Disorder Treatment Market: Company Product Type Footprint
    • 3.3.3 Cannabis Use Disorder Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cannabis Use Disorder Treatment Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Cannabis Use Disorder Treatment Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Cannabis Use Disorder Treatment Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Cannabis Use Disorder Treatment Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Cannabis Use Disorder Treatment Consumption Value by Type (2021-2032)
  • 6.2 North America Cannabis Use Disorder Treatment Market Size by Application (2021-2032)
  • 6.3 North America Cannabis Use Disorder Treatment Market Size by Country
    • 6.3.1 North America Cannabis Use Disorder Treatment Consumption Value by Country (2021-2032)
    • 6.3.2 United States Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Cannabis Use Disorder Treatment Consumption Value by Type (2021-2032)
  • 7.2 Europe Cannabis Use Disorder Treatment Consumption Value by Application (2021-2032)
  • 7.3 Europe Cannabis Use Disorder Treatment Market Size by Country
    • 7.3.1 Europe Cannabis Use Disorder Treatment Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 7.3.3 France Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Cannabis Use Disorder Treatment Consumption Value by Region (2021-2032)
    • 8.3.2 China Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 8.3.5 India Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Cannabis Use Disorder Treatment Consumption Value by Type (2021-2032)
  • 9.2 South America Cannabis Use Disorder Treatment Consumption Value by Application (2021-2032)
  • 9.3 South America Cannabis Use Disorder Treatment Market Size by Country
    • 9.3.1 South America Cannabis Use Disorder Treatment Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Cannabis Use Disorder Treatment Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Cannabis Use Disorder Treatment Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Cannabis Use Disorder Treatment Market Drivers
  • 11.2 Cannabis Use Disorder Treatment Market Restraints
  • 11.3 Cannabis Use Disorder Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cannabis Use Disorder Treatment Industry Chain
  • 12.2 Cannabis Use Disorder Treatment Upstream Analysis
  • 12.3 Cannabis Use Disorder Treatment Midstream Analysis
  • 12.4 Cannabis Use Disorder Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cannabis Use Disorder Treatment. Industry analysis & Market Report on Cannabis Use Disorder Treatment is a syndicated market report, published as Global Cannabis Use Disorder Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cannabis Use Disorder Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo